Advancements in Oncology: Targeted Therapies and the Role of LuciAsc Tablets 40mg
Among thrombopoietin receptor agonists, Avatrombopag tablets 20mg, Cabozantinib tablets 20mg, Eltrombopag 25mg, and Eltrombopag 50mg tablets stand apart for their use in persistent ITP and liver disease-associated thrombocytopenia. For ALK-positive NSCLC, Crizotinib capsules supply first-line options, while Finerenone 10mg tablets offer a distinct